BioSpace News Archive

Quanta Dialysis Technologies Ltd (“Quanta” or the “Company”), a British medical technology innovation company, today announces that management will be participating in three upcoming investor conferences. Details of the virtual conferences are as follows: Jefferies London Healthcare Conference , November 17-19, 2020 Date: Wednesday, November 18 Time: 10:35am GMT/5:35am EST Webcast: https://wsw.com/webcast/jeff141/qdtl/ Can

PharmAbcine Inc. (KOSDAQ: 208340ks) announced today that the company will present the final results of the Phase IIa clinical trial of Olinvacimab for rGBM (recurrent glioblastoma multiforme) patients at SNO (Society of Neuro-Oncology) 2020.

Happiness Biotech Group Limited (the “Company” or Nasdaq: HAPP), an innovative China -based nutraceutical and dietary supplements producer, announced today that the Company’s experience stores started offering Coenzyme Q10 - a best-selling product from Xiamen Kingdomway Group Company (“KDW”, SZSE: 002626). Coenzyme Q10 is a vi

Allergan Aesthetics, an AbbVie company, is celebrating its second annual BOTOX® Cosmetic Day on Wednesday, November 18, 2020.

Cygnal Therapeutics, the first company to build a platform to develop drugs in the new field of exoneural biology, announced that it has been named as one of Chemical & Engineering News’ 10 Start-Ups to Watch in 2020.

Flagship Pioneering, a unique life sciences innovation enterprise, today announced that it has strengthened its executive leadership team with the appointment of Luciano Rossetti, MD, as Chief Medical Officer (CMO) as well as the company’s first Head of Research & Development (R&D) for its newly formed initiative Pioneering Medicines

Seal Rock Therapeutics, Inc., a late-preclinical stage biotechnology company developing first-in-class and best-in-class treatments for severe liver diseases with limited or no available therapies, today announced the presentation of data demonstrating comparative efficacy and pharmacokinetic findings on SRT-015, a second-generation,

A partnership between Susan G. Komen®, the Inflammatory Breast Cancer (IBC) Research Foundation and the Milburn Foundation® has raised nearly $1 million for more research into inflammatory breast cancer – an aggressive subtype of breast cancer that is challenging to diagnose and treat – and other important programs.

Melinta Therapeutics, LLC (“Melinta”), a commercial-stage company focused on the development and commercialization of novel antibiotics, today announced the appointment of Kristen Allgor as Chief Human Resources Officer, effective today.

Florida Urology Partners, has enrolled their first patient in the VESAIR Clinical Trial. The VESAIR Clinical Trial is being conducted in several distinguished clinics throughout the US to test the safety and efficacy of the Vesair Bladder Control Balloon procedure.